Abstract As of 10 April 2020, New York State had 180,458 cases of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and 9,385 reported deaths. Patients with cancer …

Abstract New York State had 180,458 cases of SARS-CoV-2 and 9385 reported deaths as of
April 10 th, 2020. Patients with cancer comprised 8.4% of deceased individuals 1 …

PURPOSE Variation in risk of adverse clinical outcomes in patients with cancer and COVID-
19 has been reported from relatively small cohorts. The NCATS'National COVID Cohort …

Background Patients with cancer may be at high risk of adverse outcomes from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of …

PURPOSE SARS-CoV-2 (COVID-19) is a systemic infection. Patients with cancer are
immunocompromised and may be vulnerable to COVID-related morbidity and mortality. The …

Background COVID-19 has spread globally. Epidemiological susceptibility to COVID-19 has
been reported in patients with cancer. We aimed to systematically characterise clinical …

Background Emerging data suggest variability in susceptibility and outcome to coronavirus
disease 2019 (COVID-19) infection. Identifying risk factors associated with infection and …

Background Individuals with cancer, particularly those who are receiving systemic
anticancer treatments, have been postulated to be at increased risk of mortality from COVID …

The coronavirus disease 2019 (COVID-19) pandemic has no true precedent in modern
times and is a rapidly evolving crisis worldwide. Risk factors for severe outcomes and death …

Background: There is insufficient evidence to support clinical decision-making for cancer
patients diagnosed with COVID-19 due to the lack of large studies. Methods: We used data …